Drug Delivery to Epilepsy Brain

In treating Neurogenetic disorder with drugs, the point is to diminish the abnormality in brain recurrence and seriousness while limiting poisonous quality to the mind and different tissues. Antiepileptic drugs (AEDs) are typically managed by oral and intravenous (IV) courses, yet these drug delivery process are not generally successful. Drug delivery to the cerebrum is extremely restricted by various natural variables, especially the blood-barrier boundary (BBB), which blocks the capacity of AEDs to enter and stay in the mind. To enhance the viability of AEDs, new medication conveyance techniques are being produced.

  • Drug modification
  • BBB modification
  • Direct drug delivery
  • Anti-epileptic drug delivery
  • Pro-drugs
  • Peptide masking
  • Nanoparticles
  • Loaded microbubble-enhanced focused ultrasound
  • Adsorption-mediated transcytosis
  • Coupling of drug to a vector for receptor-mediated

Related Conference of Drug Delivery to Epilepsy Brain

Drug Delivery to Epilepsy Brain Conference Speakers